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COMBINATIONS OF ANTIMICROBIAL DRUGS
The indiscriminate use of antimicrobial drugs has been
much condemned. There are several important disadvan-
tages and dangers. The use of combinations of these drugs
introduces additional problems and risks, among which is
an increase in the incidence of adverse reactions and in
sensitization.
The possible indications for combined use of these
drugs have been stated by Jawetz.' In certain patients who
are extremely ill with infection of unknown cause, it
might be advisable to use more than one antimicrobial
drug, while every effort is being made to establish the
correct diagnosis. In mixed infections a combination of
drugs aimed at a complex flora may be more effective than
a single drug. Infections of the skin, wounds, body cavities,
and of the cardiovascular, respiratory and urinary systems,
may necessitate this form of attack. In certain infections
where resistant organisms develop, an additional drug may
delay the emergence of resistant strains. This has been
well established in the chemotherapy of tuberculosis, but
it may apply also to other chronic infections. The admini-
stration of a combination of drugs may in certain instances
decrease adverse reactions, since each of the administered
drugs may be given in a smaller dose below the level of
adverse reaction. There are occasions when one drug may
enhance the action of another on a particular micro-
organism; one of the best examples of such 'synergism' is
the use of penicillin with streptomycin in bacterial endo-
carditis due to Strept. faecalis. Desirable combinations of
drugs have to be established or suggested by appropriate
laboratory methods.
The mechanism involved in synergism is not properly
understood at present. One drug may be more effective on
one type of microorganism, and the other on the remainder
of the microbial population; or one drug may block
microbial replication incompletely and the second drug
then produce bactericidal effects. Thus the bactericidal
action of penicillin on Streptococcus viridans is enhanced
by the presence of streptomycin. The possibility of a
second drug actually diminishing the effectiveness of the
drug with which it is given in combination is also to be
borne in mind. Fortunately, in clinical practice this is not
a frequent occurrence, but there are a few documented
examples of 'antagonism'. Penicillin and chlortetracycline
(Aureomycin) were found to cure fewer patients with
pneumococcal meningitis than when penicillin was used
alone. There are other examples of such antibiotic antago-
nism. The mechanism must be the result of sequential
action whereby the interfering drug reduces the activity of
that metabolic pathway that would have been inhibited
by the bactericidal drug. An interfering agent such as tetra-
cycline acts primarily as an inhibitor of protein synthesis
and antagonizes penicillin, which acts as an inhibitor of
mucopeptide synthesis by the cell wall. It may be that
protein synthesis must proceed actively for active muco-
peptide synthesis to occur, and so inhibitors of protein
synthesis antagonize inhibitors of mucopeptide synthesis.
The results of in vitro tests have correlated very poorly
with the clinical results;' a mixture of antimicrobial drugs
is superior to a single agent only in a few instances. It is
remarkable that there has been such readiness and en-
thusiasm to accept claims made for mixtures of anti-
microbial drugs. Particularly condemned have been the
'fixed dose' forms. This use of drugs does not offer the
physician discretion in the choice of components or of the
ratios in which they are used. 'The use of such "fixed dose"
antibiotic mixtures and the manner in which they are
being exploited represent a major backward step in the
management of infections." Inadequate treatmem IS en-
couraged because there is the tendency to use the same
total dose of mixture as of a single agent. Also, a false
sense of security is created when in fact a narrower
rather than a wider coverage is supplied. Antibiotics should
generally be selected individually, each for its own value,
and administered in the proper dose for the intended
purpose.
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THE RACIAL INCIDENCE OF TESTICULAR TUMOURS*
A. J. TILTMAN, M.B., CH.B., M.MED. (PATH.) (CAPE Tow), Department of Pathology, Medical School,
University of Cape Town
It is generally accepted that tumours of the testis of the
seminoma/teratoma type are uncommon in non-White
patients. Dixon and Moore' state that only ],5% of these
tumours in their series occurred in non-Whites, although
the population at risk contained up to 8·5% non-Whites.
Kochler et al.,' in a series of 1,127 testicular tumours col-
lected from a population which contained 50% Negroes,
found only 17 cases (1'5%) in the non-White group. Cohen
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and Tomskey' found only 5 ca e (8,9%) in Negroe , out
of 56 tumours, and all of these were in undescended teste.
Oroote Sehuur Hospital, Cape Town, admits patient
from 3 racial groups: White, Bantu and a group of mixed
blood known as Cape Coloured. It was thought worth
while to study the racial incidence of testicular tumour
within this population to discover whether it followed the
same trends as elsewhere.
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MATERIALS
During the 28-year period 1940 - 1967, 62 testicular tu-
mours from patients admitted to Groote Schuur Hospital
were seen in the Department of Pathology. Slides and/ or
blocks were available for study in all cases except one
which was excluded.
Teratoma were the most frequently seen (24 cases:
39%), followed by seminomas (19 cases: 30%). Only 4
cases were examples of combined seminoma and tera-
toma. In addition there were 2 examples of interstitial-cell
tumour, 1 Sertoli-cell tumour, 1 orchioblastoma, 7 cases
regarded as primary lymphoma and 2 secondary tumours
(1 from the prostate and 1 from the large bowel). The
nature of one tumour was not decided.
The classification employed was that of the Testicular
Tumour Panel and Registry of the Pathological Society of
Great Britain and Ireland" When so classified the teratoma
group contained 1 differentiated teratoma, 14 malignant
teratomata (intermediate type A), 7 malignant teratomata
(intermediate type B), and 2 choriocarcinomas.
During the period under discussion the relative admis-
sions for the 3 racial groups were: 47% White, 44%
Coloured and 9% Bantu.
RESULTS
The majority of the seminoma/teratoma group of tumours
(6&%) occurred in the White group and only 32% in the
non-White group (Table I). Of the remaining 13 tumours,
both interstitial-cell tumours occurred in White patients,
3 of the 7 lymphomas occurred in White patients and the
remainder in Coloured patients, the single orchioblastoma
occurred in a Coloured child, the Sertoli-cell tumour 9c-
curred in a Bantu, and both secondary tumours occurred
in White patients.
TABLE I. INCIDENCE OF TESTICULAR TUMOURS
White Coloured Bantu Total
cases
Cases % Cases % Cases %
Seminoma 13 68·5 5 26 1 5 19
Teratoma 18 75 6 25 24
Combined 1 3 4
Total 32 68 14 30 2 47
The age incidence of the seminoma/teratoma group
corresponds with that of most other series, in that most
seminomas occurred during the 4th and 5th decade, while
the teratomata occurred maximally a decade earlier. There
was no difference between White and non-White with
regard to age incidence.
Four of the tumours occurred in undescended testes: an
incidence in the same range as occurred in most other
series. Of these, 2 were seminomas, 1 was a teratoma and I
a combined tumour.
DISCUSSION
The lower incidence of testicular tumours in the non-
White races is, according to the literature, restricted to the
seminoma/teratoma group. The series presented was de-
rived from a hospital population comprising 47% White
and 53% non-White patients. The incidence of these tu-
mours in the non-White group is only 32%, but is con-
siderably higher than in other series.
Comparisons of the racial incidence of a given tumour
are not valid unless the relative ages of the racial groups
are taken into account. In this population the average age
of the White patients is approximately 1 decade above
that of the Coloured, which in turn is 1 decade above that
of the Bantu. As this variation is most marked above the
age of 60 years and most of the tumours in this series
occurred below the age of 50 years, this difference in ages
has little significance.
The majority of non-White patients in this series were
Cape Coloured, and there was only 1 Bantu patient. A
single case in a small series cannot be accurately con-
verted into a percentage, but does indicate an incidence
similar to that reported in the USA. This similarity may be
of significance in that the American Negro has an Afri-
can ancestry. The Cape Coloured, on the other hand,
comprise a distinct ethnic group of European, Hottentot
and Malay descent.
It has therefore been confirmed that there is a lower
incidence of testicular tumours in the non-White races,
but that the difference is not as marked in the Cape
Coloured group as in the non-Whites of other series.
SUMMARY
The racial incidence of testicular tumours of the seminoma/
teratoma type has been investigated in a hospital population
comprising 47% White, 44% Coloured and 9% Bantu patients.
Of 47 tumours of this type seen, 32 (68%) occurred in White
patients, 14 (30%) occurred in Coloured patients and 1 occurred
in a Bantu.
As is generally accepted, the incidence of these tumours in
non-White patients is lower than in the White patients, but in
the case of the Cape Coloured this incidence is higher than
previously reported figures.
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